{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:24:51Z","timestamp":1772166291039,"version":"3.50.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:00:00Z","timestamp":1768003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Orthop Surg Res"],"DOI":"10.1186\/s13018-025-06595-1","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T08:46:54Z","timestamp":1768034814000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Preparation and in vitro sustained release performance of thermosensitive gel microsphere composite loaded with Anti-Tuberculosis drug PaMZ\/BMP-2"],"prefix":"10.1186","volume":"21","author":[{"given":"Gui","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianbo","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenxing","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Binqing","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangru","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,10]]},"reference":[{"issue":"6","key":"6595_CR1","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1111\/os.13744","volume":"15","author":"S Na","year":"2023","unstructured":"Na S, Lyu Z, Zhang S. Diagnosis and treatment of skipped multifocal spinal tuberculosis lesions. Orthop Surg. 2023;15(6):1454\u201367.","journal-title":"Orthop Surg"},{"issue":"2","key":"6595_CR2","doi-asserted-by":"publisher","first-page":"220","DOI":"10.31138\/mjr.34.2.220","volume":"34","author":"S Boussaid","year":"2023","unstructured":"Boussaid S, M\u2019rabet M, Rekik S, Jammali S, Rahmouni S, Zouaoui K, et al. Spinal tuberculosis: features and early predictive factors of poor outcomes. Mediterr J Rheumatol. 2023;34(2):220\u20138.","journal-title":"Mediterr J Rheumatol"},{"issue":"1","key":"6595_CR3","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.2106\/JBJS.RVW.18.00035","volume":"7","author":"A Ali","year":"2019","unstructured":"Ali A, Musbahi O, White V, Montgomery AS. Spinal tuberculosis: a literature review. JBJS Rev. 2019;7(1):e9.","journal-title":"JBJS Rev"},{"key":"6595_CR4","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s00586-012-2337-5","volume":"22","author":"S Rajasekaran","year":"2013","unstructured":"Rajasekaran S, Khandelwal G. Drug therapy in spinal tuberculosis. Eur Spine J. 2013;22:587\u201393.","journal-title":"Eur Spine J"},{"issue":"18","key":"6595_CR5","doi-asserted-by":"publisher","first-page":"5409","DOI":"10.3390\/jcm11185409","volume":"11","author":"G Jiang","year":"2022","unstructured":"Jiang G, Qin W, Du X, Zhang Y, Zhang M, Xiong T, et al. The distribution pattern of first-line anti-tuberculosis drug concentrations between the blood and the vertebral focus of spinal tuberculosis patients. J Clin Med. 2022;11(18):5409.","journal-title":"J Clin Med"},{"key":"6595_CR6","doi-asserted-by":"publisher","first-page":"100151","DOI":"10.1016\/j.jctube.2020.100151","volume":"19","author":"A Pandita","year":"2020","unstructured":"Pandita A, Madhuripan N, Pandita S, Hurtado RM. Challenges and controversies in the treatment of spinal tuberculosis. J Clin Tuberc Other Mycobact Dis. 2020;19:100151.","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"issue":"5","key":"6595_CR7","doi-asserted-by":"publisher","first-page":"275","DOI":"10.5312\/wjo.v14.i5.275","volume":"14","author":"W Leowattana","year":"2023","unstructured":"Leowattana W, Leowattana P, Leowattana T. Tuberculosis of the spine. World J Orthop. 2023;14(5):275\u201393.","journal-title":"World J Orthop"},{"issue":"3","key":"6595_CR8","doi-asserted-by":"publisher","first-page":"e402","DOI":"10.52225\/narra.v3i3.402","volume":"3","author":"AM Simanjuntak","year":"2023","unstructured":"Simanjuntak AM, Daenansya R, Aflandhanti PM, Yovi I, Suyanto S, Anggraini D, et al. Efficacy of pretomanid-containing regiments for drug-resistant tuberculosis: a systematic review and meta-analysis of clinical trials. Narra J. 2023;3(3):e402.","journal-title":"Narra J"},{"issue":"10","key":"6595_CR9","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1164\/rccm.201909-1874ST","volume":"200","author":"P Nahid","year":"2019","unstructured":"Nahid P, Mase SR, Migliori GB, Sotgiu G, Bothamley GH, Brozek JL, et al. Treatment of drug-resistant tuberculosis an official ATS\/CDC\/ERS\/IDSA clinical practice guideline. Am J Respir Crit Care Med. 2019;200(10):e93-93e142.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"6595_CR10","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S2213-2600(20)30047-3","volume":"8","author":"Z Lan","year":"2020","unstructured":"Lan Z, Ahmad N, Baghaei P, Barkane L, Benedetti A, Brode SK, et al. Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis. Lancet Respir Med. 2020;8(4):383\u201394.","journal-title":"Lancet Respir Med"},{"issue":"3","key":"6595_CR11","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S1473-3099(19)30575-4","volume":"20","author":"JR Campbell","year":"2020","unstructured":"Campbell JR, Trajman A, Cook VJ, Johnston JC, Adjobimey M, Ruslami R, et al. Adverse events in adults with latent tuberculosis infection receiving daily rifampicin or isoniazid: post-hoc safety analysis of two randomised controlled trials. Lancet Infect Dis. 2020;20(3):318\u201329.","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"6595_CR12","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.jsps.2020.01.011","volume":"28","author":"F Imam","year":"2020","unstructured":"Imam F, Sharma M, Khayyam KU, Al-Harbi NO, Rashid MK, Ali MD, et al. Adverse drug reaction prevalence and mechanisms of action of first-line anti-tubercular drugs. Saudi Pharm J. 2020;28(3):316\u201324.","journal-title":"Saudi Pharm J"},{"issue":"1","key":"6595_CR13","first-page":"519","volume":"19","author":"CG Jia","year":"2020","unstructured":"Jia CG, Gao JG, Liu FS, Li Z, Dong ZL, Yao LM, et al. Efficacy, safety and prognosis of treating neurological deficits caused by spinal tuberculosis within 4 weeks\u2019 standard anti-tuberculosis treatment: a single medical center\u2019s experience. Exp Ther Med. 2020;19(1):519\u201326.","journal-title":"Exp Ther Med"},{"issue":"1","key":"6595_CR14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.cmi.2021.08.007","volume":"28","author":"T Gils","year":"2022","unstructured":"Gils T, Lynen L, de Jong BC, Van Deun A, Decroo T. Pretomanid for tuberculosis: a systematic review. Clin Microbiol Infect. 2022;28(1):31\u201342.","journal-title":"Clin Microbiol Infect"},{"key":"6595_CR15","doi-asserted-by":"publisher","first-page":"100128","DOI":"10.1016\/j.crphar.2022.100128","volume":"3","author":"S Occhineri","year":"2022","unstructured":"Occhineri S, Matucci T, Rindi L, Tiseo G, Falcone M, Riccardi N, et al. Pretomanid for tuberculosis treatment: an update for clinical purposes. Curr Res Pharmacol Drug Discov. 2022;3:100128.","journal-title":"Curr Res Pharmacol Drug Discov"},{"issue":"9979","key":"6595_CR16","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1016\/S0140-6736(14)62002-X","volume":"385","author":"R Dawson","year":"2015","unstructured":"Dawson R, Diacon AH, Everitt D, van Niekerk C, Donald PR, Burger DA, et al. Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis. Lancet. 2015;385(9979):1738\u201347.","journal-title":"Lancet"},{"key":"6595_CR17","doi-asserted-by":"publisher","first-page":"123984","DOI":"10.1016\/j.ijpharm.2024.123984","volume":"654","author":"C Fan","year":"2024","unstructured":"Fan C, Eedara BB, Sinha S, Uddin M, Doyle C, Banu S, et al. Triple combination dry powder formulation of pretomanid, moxifloxacin, and pyrazinamide for treatment of multidrug-resistant tuberculosis. Int J Pharm. 2024;654:123984.","journal-title":"Int J Pharm"},{"issue":"11","key":"6595_CR18","first-page":"1032","volume":"33","author":"X Zhu","year":"2023","unstructured":"Zhu X, Li Y, Shi J, Xu R, Ding H. In vivo osteogenesis and drug release performance of 3D-printed PaMZ\/BMP-2-loaded nHA anti-tuberculosis artificial bone. Chin J Spine Spinal Cord. 2023;33(11):1032\u201342.","journal-title":"Chin J Spine Spinal Cord"},{"key":"6595_CR19","doi-asserted-by":"publisher","first-page":"112466","DOI":"10.1016\/j.msec.2021.112466","volume":"130","author":"CE Gillman","year":"2021","unstructured":"Gillman CE, Jayasuriya AC. FDA-approved bone grafts and bone graft substitute devices in bone regeneration. Mater Sci Eng C Mater Biol Appl. 2021;130:112466.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"issue":"5","key":"6595_CR20","first-page":"845","volume":"32","author":"JM Ahn","year":"2022","unstructured":"Ahn JM, Hyun SJ, Kim KJ. Safety and efficacy of a new moldable and compression resistant matrix carrier with recombinant human bone morphogenetic protein-2 in the rabbit bone defect model. Turk Neurosurg. 2022;32(5):845\u201353.","journal-title":"Turk Neurosurg"},{"issue":"8","key":"6595_CR21","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.3390\/ijms21082720","volume":"21","author":"A Krouwels","year":"2020","unstructured":"Krouwels A, Iljas JD, Kragten A, Dhert W, \u00d6ner FC, Tryfonidou MA, et al. Bone morphogenetic proteins for nucleus pulposus regeneration. Int J Mol Sci. 2020;21(8):2720.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"6595_CR22","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1097\/BSD.0000000000001301","volume":"35","author":"AM Beschloss","year":"2022","unstructured":"Beschloss AM, DiCindio CM, Lombardi JS, Shillingford JN, Laratta JL, Holderread B, et al. The rise and fall of bone morphogenetic protein 2 throughout the United States. Clin Spine Surg. 2022;35(6):264\u20139.","journal-title":"Clin Spine Surg"},{"issue":"9","key":"6595_CR23","doi-asserted-by":"publisher","first-page":"823","DOI":"10.3390\/pharmaceutics12090823","volume":"12","author":"JC Berkmann","year":"2020","unstructured":"Berkmann JC, Herrera Martin AX, Pontremoli C, Zheng K, Bucher CH, Ellinghaus A, et al. In vivo validation of spray-dried mesoporous bioactive glass microspheres acting as prolonged local release systems for BMP-2 to support bone regeneration. Pharmaceutics. 2020;12(9):823.","journal-title":"Pharmaceutics"},{"key":"6595_CR24","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.cytogfr.2015.11.006","volume":"27","author":"K Schmidt-Bleek","year":"2016","unstructured":"Schmidt-Bleek K, Willie BM, Schwabe P, Seemann P, Duda GN. BMPs in bone regeneration: less is more effective, a paradigm-shift. Cytokine Growth Factor Rev. 2016;27:141\u20138.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"3","key":"6595_CR25","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.3390\/ijms24032643","volume":"24","author":"S Wang","year":"2023","unstructured":"Wang S, Chen Y, Guo J, Huang Q. Liposomes for tumor targeted therapy: a review. Int J Mol Sci. 2023;24(3):2643.","journal-title":"Int J Mol Sci"},{"key":"6595_CR26","doi-asserted-by":"publisher","first-page":"113851","DOI":"10.1016\/j.addr.2021.113851","volume":"176","author":"DE Large","year":"2021","unstructured":"Large DE, Abdelmessih RG, Fink EA, Auguste DT. Liposome composition in drug delivery design, synthesis, characterization, and clinical application. Adv Drug Deliv Rev. 2021;176:113851.","journal-title":"Adv Drug Deliv Rev"},{"key":"6595_CR27","doi-asserted-by":"publisher","first-page":"120571","DOI":"10.1016\/j.ijpharm.2021.120571","volume":"601","author":"D Guimar\u00e3es","year":"2021","unstructured":"Guimar\u00e3es D, Cavaco-Paulo A, Nogueira E. Design of liposomes as drug delivery system for therapeutic applications. Int J Pharm. 2021;601:120571.","journal-title":"Int J Pharm"},{"issue":"4","key":"6595_CR28","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1208\/s12248-021-00611-y","volume":"23","author":"Y Wang","year":"2021","unstructured":"Wang Y, Qin B, Xia G, Choi SH. FDA\u2019s poly (lactic-co-glycolic acid) research program and regulatory outcomes. AAPS J. 2021;23(4):92.","journal-title":"AAPS J"},{"issue":"3","key":"6595_CR29","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1007\/s13346-019-00699-y","volume":"10","author":"CB Roces","year":"2020","unstructured":"Roces CB, Christensen D, Perrie Y. Translating the fabrication of protein-loaded poly(lactic-co-glycolic acid) nanoparticles from bench to scale-independent production using microfluidics. Drug Deliv Transl Res. 2020;10(3):582\u201393.","journal-title":"Drug Deliv Transl Res"},{"issue":"22","key":"6595_CR30","doi-asserted-by":"publisher","first-page":"23209","DOI":"10.1021\/acsomega.3c08917","volume":"9","author":"J Sedlarikova","year":"2024","unstructured":"Sedlarikova J, Janalikova M, Egner P, Pleva P. Poloxamer-based mixed micelles loaded with thymol or eugenol for topical applications. ACS Omega. 2024;9(22):23209\u201319.","journal-title":"ACS Omega"},{"issue":"24","key":"6595_CR31","doi-asserted-by":"publisher","first-page":"5353","DOI":"10.3390\/polym14245353","volume":"14","author":"IC Chen","year":"2022","unstructured":"Chen IC, Su CY, Chen PY, Hoang TC, Tsou YS, Fang HW. Investigation and characterization of factors affecting rheological properties of poloxamer-based thermo-sensitive hydrogel. Polymers. 2022;14(24):5353.","journal-title":"Polymers"},{"key":"6595_CR32","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ejpb.2020.10.011","volume":"157","author":"C Al Sabbagh","year":"2020","unstructured":"Al Sabbagh C, Seguin J, Agapova E, Kramerich D, Boudy V, Mignet N. Thermosensitive hydrogels for local delivery of 5-fluorouracil as neoadjuvant or adjuvant therapy in colorectal cancer. Eur J Pharm Biopharm. 2020;157:154\u201364.","journal-title":"Eur J Pharm Biopharm"},{"key":"6595_CR33","doi-asserted-by":"publisher","first-page":"106294","DOI":"10.1016\/j.ejps.2022.106294","volume":"179","author":"E Corazza","year":"2022","unstructured":"Corazza E, di Cagno MP, Bauer-Brandl A, Abruzzo A, Cerchiara T, Bigucci F, et al. Drug delivery to the brain: in situ gelling formulation enhances carbamazepine diffusion through nasal mucosa models with mucin. Eur J Pharm Sci. 2022;179:106294.","journal-title":"Eur J Pharm Sci"},{"key":"6595_CR34","unstructured":"Cao G, Wang X, Xiang X, et al. Drug-loaded thermosensitive gel microsphere controlled release composite."},{"issue":"06","key":"6595_CR35","first-page":"565","volume":"42","author":"X Tang","year":"2020","unstructured":"Tang X, Liu C, Yu S, Zeng Q, Shi J. Optimization of the formulation of PaMZ\/nHA anti-tuberculosis artificial bone. Ningxia Med Univ J. 2020;42(06):565\u201372.","journal-title":"Ningxia Med Univ J"},{"issue":"08","key":"6595_CR36","first-page":"735","volume":"32","author":"X Zhu","year":"2022","unstructured":"Zhu X, Tang X, Shi J, Zhou Z, Xie L, Ding H. In vitro drug release and anti-tuberculosis properties of 3D-printed PaMZ\/BMP-2-loaded nHA anti-tuberculosis artificial bone. Chin J Spine Spinal Cord. 2022;32(08):735\u201342.","journal-title":"Chin J Spine Spinal Cord"},{"issue":"10","key":"6595_CR37","first-page":"2334","volume":"47","author":"L Wang","year":"2024","unstructured":"Wang L, Wu W, Luo Y, Che X. Preparation of resveratrol thermosensitive gel and its effects on bladder cancer cells. Drug Eval Res. 2024;47(10):2334\u201342.","journal-title":"Drug Eval Res"},{"issue":"1","key":"6595_CR38","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1186\/s40001-024-02198-4","volume":"29","author":"J Gan","year":"2024","unstructured":"Gan J, Zhang C, Tang D, Du X. Surgical treatment of spinal tuberculosis: an updated review. Eur J Med Res. 2024;29(1):588.","journal-title":"Eur J Med Res"},{"issue":"5","key":"6595_CR39","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.jiph.2018.04.005","volume":"11","author":"MT Zaw","year":"2018","unstructured":"Zaw MT, Emran NA, Lin Z. Mutations inside rifampicin-resistance determining region of rpoB gene associated with rifampicin-resistance in Mycobacterium tuberculosis. J Infect Public Health. 2018;11(5):605\u201310.","journal-title":"J Infect Public Health"},{"issue":"3","key":"6595_CR40","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/pro.324","volume":"19","author":"CE Cade","year":"2010","unstructured":"Cade CE, Dlouhy AC, Medzihradszky KF, Salas-Castillo SP, Ghiladi RA. Isoniazid-resistance conferring mutations in Mycobacterium tuberculosis KatG: catalase, peroxidase, and INH-NADH adduct formation activities. Protein Sci. 2010;19(3):458\u201374.","journal-title":"Protein Sci"},{"issue":"9846","key":"6595_CR41","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/S0140-6736(12)61080-0","volume":"380","author":"AH Diacon","year":"2012","unstructured":"Diacon AH, Dawson R, von Groote-Bidlingmaier F, Symons G, Venter A, Donald PR, et al. 14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial. Lancet. 2012;380(9846):986\u201393.","journal-title":"Lancet"},{"issue":"1-2","key":"6595_CR42","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.ijpharm.2013.05.020","volume":"452","author":"CD Xiao","year":"2013","unstructured":"Xiao CD, Shen XC, Tao L. Modified emulsion solvent evaporation method for fabricating core-shell microspheres. Int J Pharm. 2013;452(1\u20132):227\u201332.","journal-title":"Int J Pharm"},{"issue":"3","key":"6595_CR43","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1080\/09205063.2023.2287247","volume":"35","author":"M Kouhjani","year":"2024","unstructured":"Kouhjani M, Jaafari MR, Kamali H, Abbasi A, Tafaghodi M, Mousavi Shaegh SA. Microfluidic-assisted preparation of PLGA nanoparticles loaded with insulin: a comparison with double emulsion solvent evaporation method. J Biomater Sci Polym Ed. 2024;35(3):306\u201329.","journal-title":"J Biomater Sci Polym Ed"},{"issue":"1","key":"6595_CR44","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1186\/s12951-021-01160-4","volume":"19","author":"Y Lee","year":"2021","unstructured":"Lee Y, Lee D, Park E, Jang SY, Cheon SY, Han S, et al. Rhamnolipid-coated W\/O\/W double emulsion nanoparticles for efficient delivery of doxorubicin\/erlotinib and combination chemotherapy. J Nanobiotechnology. 2021;19(1):411.","journal-title":"J Nanobiotechnology"},{"key":"6595_CR45","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jconrel.2017.01.023","volume":"249","author":"R Ni","year":"2017","unstructured":"Ni R, Muenster U, Zhao J, Zhang L, Becker-Pelster EM, Rosenbruch M, et al. Exploring polyvinylpyrrolidone in the engineering of large porous PLGA microparticles via single emulsion method with tunable sustained release in the lung: In vitro and in vivo characterization. J Control Release. 2017;249:11\u201322.","journal-title":"J Control Release"},{"key":"6595_CR46","first-page":"100102","volume":"3","author":"BV Sch\u00f6nfeld","year":"2021","unstructured":"Sch\u00f6nfeld BV, Westedt U, Wagner KG. Compression of amorphous solid dispersions prepared by hot-melt extrusion, spray drying and vacuum drum drying. Int J Pharm X. 2021;3:100102.","journal-title":"Int J Pharm X"},{"issue":"5","key":"6595_CR47","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1039\/D1LC00836F","volume":"22","author":"KS Elvira","year":"2022","unstructured":"Elvira KS, Gielen F, Tsai S, Nightingale AM. Materials and methods for droplet microfluidic device fabrication. Lab Chip. 2022;22(5):859\u201375.","journal-title":"Lab Chip"},{"issue":"6","key":"6595_CR48","doi-asserted-by":"publisher","first-page":"830","DOI":"10.3390\/polym16060830","volume":"16","author":"JH Yoon","year":"2024","unstructured":"Yoon JH, Kim T, Seo M, Kim SY. Synthesis and thermo-responsive behavior of poly(N-isopropylacrylamide)-b-poly(N-vinylisobutyramide) diblock copolymer. Polymers. 2024;16(6):830.","journal-title":"Polymers"},{"key":"6595_CR49","doi-asserted-by":"publisher","first-page":"112526","DOI":"10.1016\/j.ejmech.2020.112526","volume":"206","author":"I Jarak","year":"2020","unstructured":"Jarak I, Varela CL, da Tavares Silva E, Roleira F, Veiga F, Figueiras A. Pluronic-based nanovehicles: recent advances in anticancer therapeutic applications. Eur J Med Chem. 2020;206:112526.","journal-title":"Eur J Med Chem"},{"issue":"06","key":"6595_CR50","first-page":"430","volume":"19","author":"J Zhang","year":"2018","unstructured":"Zhang J, Wu Q. Research progress on the application of titrant solutions. Chin Drug Stand. 2018;19(06):430\u20132.","journal-title":"Chin Drug Stand"},{"issue":"11","key":"6595_CR51","first-page":"3452","volume":"43","author":"L Huang","year":"2023","unstructured":"Huang L, Ma R, Chen Y, et al. Rapid detection of multiple organophosphorus pesticides in water using UV-visible spectroscopy and parallel factor analysis. Spectrosc Spectral Anal. 2023;43(11):3452\u201360.","journal-title":"Spectrosc Spectral Anal"},{"issue":"21","key":"6595_CR52","first-page":"1625","volume":"29","author":"X Hu","year":"2023","unstructured":"Hu X, Yu J, Gan L, et al. Preparation and drug content determination of adhesive resveratrol micelles. Hainan Med Univ J. 2023;29(21):1625\u201331.","journal-title":"Hainan Med Univ J"},{"issue":"03","key":"6595_CR53","first-page":"453","volume":"55","author":"Y Gao","year":"2020","unstructured":"Gao Y, Zhong D. Advances in bioanalysis of antibody drugs by LC-MS. Acta Pharm Sin. 2020;55(03):453\u201362.","journal-title":"Acta Pharm Sin"},{"issue":"2","key":"6595_CR54","first-page":"193","volume":"48","author":"G Li","year":"2025","unstructured":"Li G, Du Q, Cao G. Research progress on anti-tuberculosis and osteogenesis-promoting sustained-release microsphere drugs in the treatment of spinal tuberculosis. Zunyi Med Univ J. 2025;48(2):193\u2013201.","journal-title":"Zunyi Med Univ J"}],"container-title":["Journal of Orthopaedic Surgery and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13018-025-06595-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-025-06595-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-025-06595-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T17:02:35Z","timestamp":1770397355000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13018-025-06595-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,10]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6595"],"URL":"https:\/\/doi.org\/10.1186\/s13018-025-06595-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7441834\/v1","asserted-by":"object"}]},"ISSN":["1749-799X"],"issn-type":[{"value":"1749-799X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,10]]},"assertion":[{"value":"23 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the principles of the Declaration of Helsinki. The study methodology and ethics were reviewed and approved by the Institutional Review Board of Zunyi Medical University. Written informed consent was obtained from all participants prior to their enrollment in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication was obtained from the participant.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publications"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"101"}}